[Fundamental and clinical evaluation of IRMA for serum pancreatic oncofetal antigen (POA) in pancreatic cancer]. 1989

K Honjo, and F Hirano, and N Sakai, and S Uehara, and A Hirayama, and T Nakamura, and K Ihara, and H Tanaka

UI MeSH Term Description Entries
D010190 Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA). Cancer of Pancreas,Pancreatic Cancer,Cancer of the Pancreas,Neoplasms, Pancreatic,Pancreas Cancer,Pancreas Neoplasms,Pancreatic Acinar Carcinoma,Pancreatic Carcinoma,Acinar Carcinoma, Pancreatic,Acinar Carcinomas, Pancreatic,Cancer, Pancreas,Cancer, Pancreatic,Cancers, Pancreas,Cancers, Pancreatic,Carcinoma, Pancreatic,Carcinoma, Pancreatic Acinar,Carcinomas, Pancreatic,Carcinomas, Pancreatic Acinar,Neoplasm, Pancreas,Neoplasm, Pancreatic,Neoplasms, Pancreas,Pancreas Cancers,Pancreas Neoplasm,Pancreatic Acinar Carcinomas,Pancreatic Cancers,Pancreatic Carcinomas,Pancreatic Neoplasm
D011933 Reagent Kits, Diagnostic Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use. Diagnostic Reagent Kits,Diagnostic Reagents and Test Kits,Diagnostic Test Kits,In Vitro Diagnostic Device,In Vitro Diagnostic Devices,In Vitro Diagnostic Medical Device,In Vitro Diagnostic Medical Devices,Kits, Diagnostic Reagent,Diagnostic Reagent Kit,Diagnostic Test Kit,Kit, Diagnostic Reagent,Kit, Diagnostic Test,Kits, Diagnostic Test,Reagent Kit, Diagnostic,Test Kit, Diagnostic,Test Kits, Diagnostic
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers
D015592 Immunoradiometric Assay Form of radioimmunoassay in which excess specific labeled antibody is added directly to the test antigen being measured. Assay, Immunoradiometric,Assays, Immunoradiometric,Immunoradiometric Assays

Related Publications

K Honjo, and F Hirano, and N Sakai, and S Uehara, and A Hirayama, and T Nakamura, and K Ihara, and H Tanaka
February 1988, Kaku igaku. The Japanese journal of nuclear medicine,
K Honjo, and F Hirano, and N Sakai, and S Uehara, and A Hirayama, and T Nakamura, and K Ihara, and H Tanaka
February 1989, Rinsho byori. The Japanese journal of clinical pathology,
K Honjo, and F Hirano, and N Sakai, and S Uehara, and A Hirayama, and T Nakamura, and K Ihara, and H Tanaka
August 1983, Gan to kagaku ryoho. Cancer & chemotherapy,
K Honjo, and F Hirano, and N Sakai, and S Uehara, and A Hirayama, and T Nakamura, and K Ihara, and H Tanaka
December 1984, Nihon Gan Chiryo Gakkai shi,
K Honjo, and F Hirano, and N Sakai, and S Uehara, and A Hirayama, and T Nakamura, and K Ihara, and H Tanaka
December 1999, Nihon rinsho. Japanese journal of clinical medicine,
K Honjo, and F Hirano, and N Sakai, and S Uehara, and A Hirayama, and T Nakamura, and K Ihara, and H Tanaka
February 1983, Gan to kagaku ryoho. Cancer & chemotherapy,
K Honjo, and F Hirano, and N Sakai, and S Uehara, and A Hirayama, and T Nakamura, and K Ihara, and H Tanaka
April 1990, Kaku igaku. The Japanese journal of nuclear medicine,
K Honjo, and F Hirano, and N Sakai, and S Uehara, and A Hirayama, and T Nakamura, and K Ihara, and H Tanaka
August 1984, Nihon Gan Chiryo Gakkai shi,
K Honjo, and F Hirano, and N Sakai, and S Uehara, and A Hirayama, and T Nakamura, and K Ihara, and H Tanaka
September 1982, Rinsho byori. The Japanese journal of clinical pathology,
K Honjo, and F Hirano, and N Sakai, and S Uehara, and A Hirayama, and T Nakamura, and K Ihara, and H Tanaka
April 1981, Hepato-gastroenterology,
Copied contents to your clipboard!